AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (942.7 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Fusion genes in cancers: Biogenesis, functions, and therapeutic implications

Haiqiong Tanga,b,1Qiu Penga,c,1Linda Oyanga,cShiming Tana,cXianjie Jianga,cZongyao Rena,cXuemeng Xua,cMengzhou Shena,b,cHaofan Lia,b,cMingjing Penga,cLongzheng Xiaa,cWenjuan Yanga,cShizhen Lia,bJiewen Wanga,b,cYaqian Hana,cNayiyuan Wua,cYanyan Tanga,cJinguan Lina,cQianjin Liaod( )Yujuan Zhoua,b,c( )
The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism Changsha, Hunan 410013, China
University of South China, Hengyang, Hunan 421001, China
Hunan Engineering Research Center of Tumor Organoid Technology and Application, Public Service Platform of Tumor Organoids Technology, Changsha, Hunan 410013, China
Department of Oncology, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, China

1 These authors contributed equally to this work.

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

Show Author Information

Abstract

The processes of tumorigenesis and development are intricate, involving numerous genes and molecular pathways. Fusion genes, direct products of abnormal chromosomal rearrangements, are key factors in the formation of many types of tumors. In recent years, the advent of sequencing technology and bioinformatics has led to the discovery of more fusion genes associated with specific types of tumors. The objective of this review is to undertake a comprehensive examination of the discovery and functional mechanisms of fusion genes present in a range of cancers. This will include an analysis of their impact on the biological properties of tumor cells. This review will examine the most prevalent types of fusion genes observed in representative tumor types, including hematological tumors, lung cancer, soft tissue sarcomas, thyroid cancer, and prostate cancer. We provide an overview of the roles and clinical significance of fusion genes, as well as a summarization of the therapeutic strategies for fusion genes, including the application of targeted drugs and related studies. This review presents a comprehensive analysis of the function of fusion genes in the development and treatment of tumors, providing guidance and insights for future research and clinical practice.

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101536

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Tang H, Peng Q, Oyang L, et al. Fusion genes in cancers: Biogenesis, functions, and therapeutic implications. Genes & Diseases, 2025, 12(5): 101536. https://doi.org/10.1016/j.gendis.2025.101536

803

Views

12

Downloads

11

Crossref

11

Web of Science

11

Scopus

0

CSCD

Received: 10 September 2024
Revised: 28 November 2024
Accepted: 18 December 2024
Published: 20 January 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).